XBI
ETF
Biotechnology
NYSEARCA
SPDR S&P Biotech ETF
$159.39
+1.98 (+1.26%)
Fund Overview
by SPDR (State Street)
Equal-weighted biotech ETF. Gives small-cap clinical-stage biotech companies equal weight with large-cap pharma-like biotechs, creating a higher risk/reward profile. When biotech M&A heats up, XBI often outperforms.
AUM$6.5B
Expense Ratio0.35%
Holdings145
Dividend Yield0.1%
DistributionQuarterly
BenchmarkS&P Biotechnology Select Industry Index
InceptionJan 2006
ExchangeNYSEARCA
Price Data
Open$157.18
Prev Close$157.41
Day Range$155.86 — $159.77
52W Range$66.66 — $132.09
52-Week Range
$66.66
$132.09
From 52W High
20.7%
From 52W Low
+139.1%
Investment Calculator
See how much dividend income XBI could generate based on its current price of $159.39 and 0.1% yield. Adjust the amount to estimate your quarterly distributions.
$
Shares Purchased
Amount Invested$9,882.18
Annual Income$9.88
Monthly Income$0.82
Based on current dividend yield of 0.1%. Actual distributions may vary. Past dividends do not guarantee future payments.
Biotechnology ETF Comparison
Top Biotechnology Stocks
View all →
| Stock | Price | Change | Market Cap |
|---|---|---|---|
| ABBV | $261.83 | -1.56% | 443.23B |
| AMGN | $433.73 | -1.95% | 225.90B |
| GILD | $143.44 | -2.82% | 169.87B |
| VRTX | $540.26 | -2.14% | 135.24B |
| REGN | $826.64 | -1.69% | 82.16B |
| NTRA | $324.84 | -0.07% | 44.64B |
| RVMD | $211.74 | -1.36% | 43.21B |
| BIIB | $214.35 | -3.25% | 31.05B |
| ALNY | $229.30 | -5.49% | 30.39B |
| INSM | $125.08 | -4.27% | 28.45B |
XBI FAQ
What is XBI?
XBI is the SPDR S&P Biotech ETF, an exchange-traded fund managed by SPDR (State Street). It tracks the S&P Biotechnology Select Industry Index and holds 145 Biotechnology securities with an expense ratio of 0.35%.
What is the expense ratio of XBI?
XBI charges an annual expense ratio of 0.35%, which means you pay $35.00 per year for every $10,000 invested. This fee is deducted automatically from the fund's returns.
Does XBI pay dividends?
Yes, XBI pays a 0.1% dividend yield, distributed quarterly. On a $10,000 investment, that works out to approximately $10.00 per year in dividend income.
Explore Biotechnology Stocks
View our full list of individual biotechnology stocks with prices, fundamentals, and analyst ratings.
Last updated: Aug 17, 2026 at 5:00 PM ET